Explore Targets

Theralink → Explore Targets

T-Cell-Exhaustion-Pathway1

B-Cell-Receptor-Signaling1

Pathways created with BioRender.com

Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company